We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
EAM
26
Eventide Asset Management
Massachusetts
$4.01M +$3.86M +276,200 New
DCM
27
DAFNA Capital Management
California
$3.71M -$145K -10,350 -4%
Northern Trust
28
Northern Trust
Illinois
$3.55M +$6.68K +478 +0.2%
Walleye Capital
29
Walleye Capital
New York
$2.16M -$775K -55,471 -27%
Citadel Advisors
30
Citadel Advisors
Florida
$2.02M -$472K -33,759 -19%
JP Morgan Chase
31
JP Morgan Chase
New York
$1.98M -$107K -7,657 -5%
Renaissance Technologies
32
Renaissance Technologies
New York
$1.8M -$1.47M -105,270 -46%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$1.66M -$126K -9,000 -7%
AAA
34
Affinity Asset Advisors
New York
$1.4M +$1.35M +96,318 New
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.39M +$415K +29,704 +45%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.2M +$134K +9,597 +13%
Nuveen
37
Nuveen
North Carolina
$1.16M +$7.48K +535 +0.7%
NFGH
38
Nan Fung Group Holdings
Hong Kong
$1.14M
Charles Schwab
39
Charles Schwab
California
$916K +$3.03K +217 +0.3%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$859K -$212K -15,171 -20%
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$839K +$808K +57,800 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$642K -$150K -10,707 -19%
BC
43
Birchview Capital
Vermont
$580K
AC
44
Apogem Capital
New York
$548K -$337K -24,103 -39%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$544K +$39.8K +2,844 +8%
Morgan Stanley
46
Morgan Stanley
New York
$448K -$397K -28,437 -48%
T. Rowe Price Associates
47
T. Rowe Price Associates
Maryland
$391K +$83.1K +5,947 +28%
EW
48
Evoke Wealth
California
$371K
GCP
49
GSA Capital Partners
United Kingdom
$250K -$299K -21,414 -55%
AllianceBernstein
50
AllianceBernstein
Tennessee
$248K +$27.5K +1,964 +13%